CVRx (CVRX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Core Viewpoint - The market anticipates CVRx to report a year-over-year increase in earnings driven by higher revenues, with a focus on how actual results compare to estimates [1][2]. Financial Expectations - CVRx is expected to report a quarterly loss of $0.56 per share, reflecting a year-over-year change of +46.2% [3]. - Revenues are projected to be $12.3 million, which is an increase of 14.2% from the same quarter last year [3]. Estimate Revisions - The consensus EPS estimate has been revised down by 3.36% over the last 30 days, indicating a reassessment by analysts [4]. - The Most Accurate Estimate for CVRx is lower than the Zacks Consensus Estimate, resulting in an Earnings ESP of -26.04% [10][11]. Earnings Surprise Prediction - The Zacks Earnings ESP model suggests that a positive or negative reading indicates the likely deviation of actual earnings from the consensus estimate, with a strong predictive power for positive readings [7][8]. - CVRx currently holds a Zacks Rank of 3, making it challenging to predict an earnings beat conclusively [11]. Historical Performance - In the last reported quarter, CVRx was expected to post a loss of $0.37 per share but actually reported a loss of $0.43, resulting in a surprise of -16.22% [12]. - The company has not surpassed consensus EPS estimates in any of the last four quarters [13]. Industry Comparison - Another player in the medical instruments industry, RxSight, is expected to report earnings per share of $0.04 for the same quarter, indicating a year-over-year change of +66.7% [17]. - RxSight's revenues are expected to be $37.89 million, up 28.4% from the previous year, but it also has a negative Earnings ESP of -46.67% [18].